CERE - Cerevel Therapeutics Holdings Inc
IEX Last Trade
21.75
1.200 5.517%
Share volume: 1,794,722
Last Updated: Tue 08 Aug 2023 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$20.55
1.20
5.84%
View ratios
Fiscal Date | |
---|---|
Fiscal Quarter | |
Report Date | |
Total revenue | |
Cost of revenue | |
Gross profit | |
Operating expenses | |
Selling general and admin | |
Research and development | |
Total expenses | |
Operating income | |
Ebit | |
Pretax income | |
Income tax | |
Net income basic | |
Net income |